CompaniesAlaxia

Alaxia

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

2

As Collaborator

0

Total Enrollment

210

By Phase

PHASE2: 1PHASE1: 1

By Status

UNKNOWN: 1TERMINATED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Today
NCT02598999
Hover over trial bars to see details

Recent Trials

NCT04582786Lead Sponsor
Dose Finding Study of STR-324
PHASE2Unknown
118 participants
Started: Dec 1, 2020 · Completed: Jan 31, 2022
NCT02598999Lead Sponsor
Dose Escalation Study of ALX-009 in Healthy Men and Cystic Fibrosis (CF) and Non-CF Bronchiectasis Patients
PHASE1Terminated
92 participants
Started: Nov 30, 2015 · Completed: Dec 31, 2021